Clinical Trials: EU Law

Department of Health and Social Care written question – answered on 24th January 2020.

Alert me about debates like this

Photo of Daniel Zeichner Daniel Zeichner Labour, Cambridge

To ask the Secretary of State for Health and Social Care, what his policy is on alignment with the forthcoming EU Clinical Trial Regulation (Regulation (EU) No 536/2014) after the UK has left the EU.

Photo of Nadine Dorries Nadine Dorries The Parliamentary Under-Secretary for Health and Social Care

The Medicines and Healthcare products Regulatory Agency (MHRA), Health Research Authority, ethics services, National Institute for Health Research, National Health Service and devolved administrations have been preparing to implement the forthcoming European Union Clinical Trials Regulation since it was agreed in 2014. The United Kingdom will implement those aspects of the regulation which best suits the interests of UK patients, industry, non-commercial researchers and hospitals when it comes into force and this is currently expected during 2022.

Regardless of the terms of our exit, we will ensure that we are at the forefront of clinical trials internationally and that the UK remains a competitive environment in which to conduct clinical trials.

Does this answer the above question?

Yes0 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.